Follow
Irina Starostina
Irina Starostina
Казанский (Приволжский) государственный университет
Verified email at kpfu.ru - Homepage
Title
Cited by
Cited by
Year
Determination of metabolic viability and cell mass using a tandem resazurin/sulforhodamine B assay
FSG Silva, IG Starostina, VV Ivanova, AA Rizvanov, PJ Oliveira, ...
Current protocols in toxicology 68 (1), 2.24. 1-2.24. 15, 2016
482016
Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: Comparing with extracellular vesicles derived from mesenchymal stem cells
MO Gomzikova, AM Aimaletdinov, OV Bondar, IG Starostina, ...
Scientific reports 10 (1), 1-13, 2020
212020
Дисферлинопатии: возможности диагностики, моделирования и генно-клеточной терапии
АА Старостина, И. Г., Соловьева, В. В., Юрьева, К. С., Шевченко, К. Г ...
Гены и клетки 8 (3), 62-70, 2013
62013
Modeling and gene therapy of dysferlinopathy.
IG Starostina, VV Solovyeva, KS Yuryeva, KG Shevchenko, VP Fedotov, ...
Cellular Transplantation & Tissue Engineering 8 (3), 2013
22013
Mutation correction in exons 3 and 26 of DYSF gene by artificial trans-splicing
IA Yakovlev, RV Deev, AA Rizvanov, VV Solovyeva, IG Starostina, ...
Human gene therapy 27 (S), 2016
12016
Intranasal Administration of Microvesicles in the Brain of Mice with Induced Model of Alzheimer’s Type of Neurodegeneration
D Zhdanova, M Gomzikova, N Bobkova, I Starostina, V Kovalev, ...
BioNanoScience 12 (2), 685-692, 2022
2022
Mesenchymal stem cells derived microvesicles convey mesenchymal phenotype to recipient cells
S Kurbangaleeva, S Kletukhina, I Starostina, A Rizvanov, M Gomzikova
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 50, 85-85, 2020
2020
Gene modification of HEK293A cells using CRISPR-Cas9 SAM technology for the transcriptional activation of dysferlin gene
IG Starostina, AA Shaimardanova, DR Agliullina, VV Solovyeva, ...
HUMAN GENE THERAPY 30 (11), A190-A190, 2019
2019
Assessment of exon-skipping feasibility for treatment of dysferlinopathy
IA Iakovlev, RV Deev, DO Buev, VV Solovyeva, IG Starostina, ...
HUMAN GENE THERAPY 30 (11), A166-A166, 2019
2019
Biosynthesis of DYSF protein in Bla/J dysferlin-deficient mice after administration of recombinant adenovirus encoding dysferlin cDNA
IG Starostina, AA Shaimardanova, VV Solovyeva, AA Titova, ...
HUMAN GENE THERAPY 29 (12), A138-A138, 2018
2018
Transcriptional activation of mutant dysferlin gene expression in human skin fibroblasts using CRISPR/Cas9 SAM technology
AA Shaimardanova, IG Starostina, VV Solovyeva, DR Agliullina, ...
HUMAN GENE THERAPY 29 (12), A142-A142, 2018
2018
Generation and Analysis of Genetically Modified CD14+ Monocytes with Dysferlin Overexpression
I Starostina, V Soloveva, A Shaimardanova, R Deev, A Isaev, A Rizvanov
Blood 130, 5565, 2017
2017
DNA and RNA editing of DYSF gene exon 26 for dysferlinopathy treatment
IA Yakovlev, IG Starostina, AA Shaimardanova, VV Solovyeva, ...
HUMAN GENE THERAPY 28 (12), A65-A65, 2017
2017
Generation and functional analysis in vitro of recombinant pCMV-DYSF plasmid encoding human DYSF gene
IG Starostina, VV Solovyeva, AA Shaimardanova, RV Deev, AA Isaev, ...
HUMAN GENE THERAPY 28 (12), A125-A125, 2017
2017
Effects of Ad5-DYSF transduction on skeletal muscles of dysferlin-deficient mice
ON Chernova, AA Titova, MO Mavlikeev, IA Yakovlev, VV Solovyeva, ...
HUMAN GENE THERAPY 28 (12), A43-A43, 2017
2017
Metabolic remodeling of human skin fibroblasts as model for studying mitochondrial diseases and drug-induced toxicity
SP Pereira, TL Serafim, T Cunha-Oliveira, CM Deus, IG Starostina, ...
European Journal of Clinical Investigation 46 (1), 6-119, 2016
2016
Establishing a new model for toxicological evaluation combining Sulforhodamine B and resazurin in human cells
FSG Silva, IG Starostina, VV Ivanova, AA Rizvanov, PJ Oliveira, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 46, 66-66, 2016
2016
Involvement of sirtuin 1 and 3 on resveratrol cytotoxicity and differentiation of breast cancer cell lines
CM Deus, TL Serafim, SM Novais, A Vilaca, IG Starostina, VV Ivanova, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 46, 61-62, 2016
2016
Genetically engineered construction and creation of a recombinant adenovirus as an approach for gene therapy of dysferlinopathies
IG Starostina, VV Solovyova, AA Rizvanov, R Deev
MEDICINE 95 (10), 2016
2016
Serum of patients with auto-immune diseases demonstrates higher affinity toward genomic DNA, RNA and mitochondrial DNA from immortalized HEK 293FT cells
VV Ivanova, SF Khaiboullina, IG Starostina, AA Rizvanov
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 45, 52-52, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20